menu
    • menu

    Company profile for ChemomAb

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ChemomAb is a clinical-stage biotech company focusing on the development of targeted innovative therapeutics for fibrosis-related diseases with great unmet need. ChemomAb is planning to initiate three Phase II clinical trials in the orphan indications Primary Sclerosing Cholangitis and Systemic Sclerosis, as well as in non-alcoholic steatohepatitis (NASH) patients, supported by the company's lead investors that include OrbiMed...
    ChemomAb is a clinical-stage biotech company focusing on the development of targeted innovative therapeutics for fibrosis-related diseases with great unmet need. ChemomAb is planning to initiate three Phase II clinical trials in the orphan indications Primary Sclerosing Cholangitis and Systemic Sclerosis, as well as in non-alcoholic steatohepatitis (NASH) patients, supported by the company's lead investors that include OrbiMed and Thiel Capital.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ChemomAbIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    ChemomAb Ltd. Kiryat Atidim, Building 7, Entrance 2 Tel Aviv
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.chemomab.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Chemomab Joins Oppenheimer's Rare Disease Summit
    Chemomab Joins Oppenheimer's Rare Disease Summit

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193438/0/en/Chemomab-to-Participate-in-Oppenheimer-s-Movers-in-Rare-Disease-Summit.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Chemomab Therapeutics Reports Q3 2025 Results and Corporate
    Chemomab Therapeutics Reports Q3 2025 Results and Corporate

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3191873/0/en/Chemomab-Therapeutics-Announces-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    Chemomab Presents Nebokitug Ph 2 Trial Data At AASLD
    Chemomab Presents Nebokitug Ph 2 Trial Data At AASLD

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3182478/0/en/Chemomab-Announces-Multiple-Presentations-at-AASLD-The-Liver-Meeting-2025-Featuring-Clinical-Data-from-the-Nebokitug-Phase-2-Trial-in-Primary-Sclerosing-Cholangitis.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Chemomab Therapeutics at H.C. Wainwright 27th Global Conference
    Chemomab Therapeutics at H.C. Wainwright 27th Global Conference

    21 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/21/3137088/0/en/Chemomab-Therapeutics-to-Present-at-H-C-Wainwright-27th-Annual-Global-Investment-Conference.html

    GLOBENEWSWIRE
    21 Aug 2025
    Share Share
    Chemomab Therapeutics Reports Q2 2025 Financials, Updates
    Chemomab Therapeutics Reports Q2 2025 Financials, Updates

    14 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/14/3133435/0/en/Chemomab-Therapeutics-Announces-Second-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    14 Aug 2025
    Share Share
    Chemomab to Present Positive Nebokitug Phase 2 Data at BSG Live
    Chemomab to Present Positive Nebokitug Phase 2 Data at BSG Live

    30 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/30/3107409/0/en/Chemomab-Announces-Oral-Presentation-of-Positive-Nebokitug-Phase-2-Clinical-Data-in-Primary-Sclerosing-Cholangitis-at-BSG-Live-25.html

    GLOBENEWSWIRE
    30 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search